Adam Rosenstein

636 total citations
9 papers, 199 citations indexed

About

Adam Rosenstein is a scholar working on Immunology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Adam Rosenstein has authored 9 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Adam Rosenstein's work include Inflammatory Bowel Disease (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and T-cell and B-cell Immunology (2 papers). Adam Rosenstein is often cited by papers focused on Inflammatory Bowel Disease (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and T-cell and B-cell Immunology (2 papers). Adam Rosenstein collaborates with scholars based in United States, Spain and Hong Kong. Adam Rosenstein's co-authors include Saurabh Mehandru, Jean‐Frédéric Colombel, Sudarshan Paramsothy, Leo Porter, Mathieu Uzzan, Huaibin M. Ko, Kamron Pourmand, Jian Wang, Zhaoxiang Bian and Baojin Zhou and has published in prestigious journals such as Annals of the New York Academy of Sciences, European Journal of Pharmacology and Mucosal Immunology.

In The Last Decade

Adam Rosenstein

8 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Rosenstein United States 6 78 48 40 38 22 9 199
Arina Tamborska United Kingdom 8 32 0.4× 41 0.9× 82 2.0× 22 0.6× 47 2.1× 13 285
Pearce United Kingdom 10 76 1.0× 40 0.8× 47 1.2× 9 0.2× 13 0.6× 26 363
Youfang Liu United States 9 77 1.0× 10 0.2× 72 1.8× 49 1.3× 27 1.2× 17 271
Emanuele Garzia Italy 10 30 0.4× 160 3.3× 102 2.5× 27 0.7× 14 0.6× 19 391
Evangeline Pierce United States 12 23 0.3× 48 1.0× 16 0.4× 35 0.9× 14 0.6× 69 447
Ryan Chu Hong Kong 9 73 0.9× 38 0.8× 112 2.8× 39 1.0× 13 0.6× 22 373
Aaron Broun United States 8 41 0.5× 25 0.5× 214 5.3× 32 0.8× 17 0.8× 12 360
Aritânia Sousa Santos Brazil 14 96 1.2× 71 1.5× 75 1.9× 31 0.8× 82 3.7× 29 348

Countries citing papers authored by Adam Rosenstein

Since Specialization
Citations

This map shows the geographic impact of Adam Rosenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Rosenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Rosenstein more than expected).

Fields of papers citing papers by Adam Rosenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Rosenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Rosenstein. The network helps show where Adam Rosenstein may publish in the future.

Co-authorship network of co-authors of Adam Rosenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Rosenstein. A scholar is included among the top collaborators of Adam Rosenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Rosenstein. Adam Rosenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Canales-Herrerías, Pablo, Mathieu Uzzan, Akihiro Seki, et al.. (2024). OP39 Vedolizumab response in ulcerative colitis associates with reduced IgG+ plasma cells and FcγR signaling. Journal of Crohn s and Colitis. 18(Supplement_1). i69–i70.
2.
Rosenstein, Adam, et al.. (2020). Identifying the Prevalence of the Impostor Phenomenon Among Computer Science Students. 30–36. 41 indexed citations
3.
Li, Yanhong, Wei Sun, Baojin Zhou, et al.. (2019). iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis. European Journal of Pharmacology. 850. 167–179. 20 indexed citations
4.
Paramsothy, Sudarshan, Adam Rosenstein, Saurabh Mehandru, & Jean‐Frédéric Colombel. (2018). The current state of the art for biological therapies and new small molecules in inflammatory bowel disease. Mucosal Immunology. 11(6). 1558–1570. 85 indexed citations
5.
Uzzan, Mathieu, Huaibin M. Ko, Adam Rosenstein, et al.. (2017). Efficient long‐term depletion of CD20+ B cells by rituximab does not affect gut‐resident plasma cells. Annals of the New York Academy of Sciences. 1415(1). 5–10. 23 indexed citations
6.
Rosenstein, Adam, Marcie Rabin, & Roger Kurlan. (2015). Augmentation in Restless Legs Syndrome: Treatment with Gradual Medication Modification. The Open Neurology Journal. 9(1). 4–6. 1 indexed citations
7.
Rabin, Marcie, et al.. (2015). Complementary Therapies for Parkinson's Disease: What's Promoted, Rationale, Potential Risks and Benefits. Movement Disorders Clinical Practice. 2(3). 205–212. 11 indexed citations
8.
Rosenstein, Adam, Brian C Machler, & Elliot D. Rosenstein. (2014). Alopecia areata universalis complicating daclizumab therapy for uveitis.. PubMed. 93(5). E13–6. 4 indexed citations
9.
Krugner‐Higby, Lisa, et al.. (2003). Inguinal hernias, endometriosis, and other adverse outcomes in rhesus monkeys following lead exposure. Neurotoxicology and Teratology. 25(5). 561–570. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026